ATEC Alphatec Holdings, Inc.
USHealthcareAs of 2026-07-10 16:00
Why ATEC matters now
Alphatec Holdings, Inc. (ATEC) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.58 with +0.74% on the session and $1.47B in market capitalization; recent performance reads 1-month +7.18% and YTD -58.13%.
The latest financial table shown here is Q1 2026, with revenue of $192.1M, net income of $-33.9M, and EPS of $-0.22. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 0.5%.
The latest indexable market news headline is "Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $15.00; recent insider activity includes MCGINNIS KAREN K filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
74.34
P/S
1.72
EV/EBITDA
-1341.72
DCF Value
$14.16
FCF Yield
0.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.3%
Operating Margin
-7.2%
Net Margin
-15.9%
ROE
-443.1%
ROA
-15.7%
ROIC
-8.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $192.1M | $-33.9M | $-0.22 |
| Q4 2025 | $212.9M | $-21.7M | $-0.15 |
| FY 2025 | $764.2M | $-143.4M | $-0.96 |
| Q3 2025 | $196.5M | $-28.6M | $-0.19 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$18.00
Target (Median)
$15.00
Target Range
$14.00 - $24.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.87
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.